SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000880984-22-000014
Filing Date
2022-11-15
Accepted
2022-11-15 19:40:31
Documents
1
Period of Report
2022-11-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3421
  Complete submission text file 0000880984-22-000014.txt   4921
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address
Javitt Daniel C. (Reporting) CIK: 0001864534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 221392643